Skip to content
DataLookout
Menu

NCT07629687

Non-invasive Auricular Vagus Nerve Stimulation (taVNS) on Postural Control and Autonomic Responses in Stroke

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 8 words
    • Trial completed
    • Study completion date changed from estimate of Nov 20, 2026 to Oct 20, 2026
    • Site details revised
  2. Notable Recruitment opened
    • Interventions: Balance Training Group (Other), Vagus Nerve Stimulation + Balance Training Group (Other) to Balance Training Group (Other), Vagus Nerve Stimulation combined with Balance Training Group (Other)
    • Site details revised
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Berg Balance Scale (BBS)
Timeframe: 4 Weeks
Timed Up and Go Test (TUG)
Timeframe: 4 Weeks
Postural Assessment Scale for Stroke Patients (PASS)
Timeframe: 4 Weeks
Fugl-Meyer Assessment - Lower Extremity (FMA-LE)
Timeframe: 4 Weeks
Heart Rate Variability (HRV)
Timeframe: 4 Weeks
Blood Pressure Variability (BPV)
Timeframe: 4 Weeks
Skin Conductance and Skin Temperature
Timeframe: 4 Weeks

Arms and interventions

Vagus Nerve Stimulation combined with Balance TrainingExperimental

Participants in the experimental group will receive transcutaneous auricular vagus nerve stimulation (taVNS) administered according to standardized clinical protocols. No intervention is provided at baseline, aside from initial assessments. During Weeks 1 and 2, taVNS will be applied daily or as per a specified schedule. The stimulation parameters include: application at the auricular site (such as the tragus), with a frequency of 25 Hz, pulse width of 250 µs, and intensity adjusted to individual tolerance, not exceeding 6 mA. Each session will last for 30 minutes. The same taVNS protocol continues through Weeks 3 and 4. This group will not perform physical balance exercises during the taVNS phase, focusing solely on neuromodulation through vagus nerve stimulation.

Balance TrainingActive comparator

Participants in the control group will also undergo baseline assessments without intervention. During Weeks 1 and 2, they will participate in daily or scheduled 30-minute balance training sessions, consisting of 14 basic exercises such as sit-to-stand, tandem stance, and single-leg stance. These exercises are designed to improve static and dynamic balance, and are tailored to the individual's ability and safety level. In Weeks 3 and 4, the balance training progresses in difficulty. This includes increasing repetitions or duration, adding dual-task challenges (like cognitive tasks while balancing), and incorporating tools like foam pads or wobble boards to increase instability and challenge postural control. Each session remains 30 minutes in length and is supervised for safety and consistency.

Other: Vagus Nerve Stimulation combined with Balance Training Group, Balance Training Group

Sites

1 site in 1 country

  • Railway General Hospital, RawalpindiIslamabad, Punjab Province, Pakistan